Antisera have been raised against two peptides from the sequence of D2 dopamine receptors: peptide 1 from the predicted second extracellular loop and peptide 2 from the predicted third intracellular loop. The antisera recognize specifically a 95 kDa band in Western blots of several bovine brain regions, which corresponds to the denatured D2 dopamine receptor, whereas in recombinant CHO cells expressing D2
INTRODUCTION
Receptors for the neurotransmitter dopamine have been classified in biochemical and pharmacological studies into two subtypes, D1 and D2 (Kebabian and Calne, 1979; Creese and Fraser, 1987) . The application of gene cloning to dopamine receptors has, however, identified additional isoforms, and it is now important to understand the function of these isoforms. For example a family of D2-like dopamine receptors has been recognized by gene cloning, termed D2(short)' D2(long)9 D3 and D4 receptors (Bunzow et al., 1988; Dal Toso et al., 1989; Sokoloffet al., 1990; Van Tol et al., 1991 ; reviewed by Strange, 1990 Strange, , 1991a .
Studies are now in progress to determine the properties of these isoforms, their function and their tissue locations. Information on the tissue location may be obtained by examining the distribution of the mRNA for the isoforms by using hybridization in situ, the polymerase chain reaction and solution hybridization/protection (see, e.g., Giros et al., 1989; Mansour et al., 1990; O'Malley et al., 1990; Gandleman et al., 1991; Snyder et al., 1991) . The distribution of receptor protein may not directly parallel the distribution of mRNA, so that it is necessary also to perform studies at the expressed protein level. Some information on the distribution of the receptor protein may be obtained by using ligand autoradiography (Mansour et al., 1990) or by purifying receptors from different tissues (Chazot and Strange, 1992b; Strange, 1992) , but these methods do not directly distinguish the isoforms. Immunological methods with isoformselective antisera should in principle be very powerful for determining the isoform protein distribution. This paper describes the development of two antisera directed against the D2(short) and D2(long) 
Preparation of peptide conjugates
Crude peptide (30 mg) was dissolved in 2 ml of 0.1 M (NH4)2CO3/2.5 mM mercaptoethanol (for peptide-1 only) and applied to a 20 ml Bio-Gel P2 column, equilibrated in the same buffer. The column was eluted with buffer at a flow rate of 10 ml/h, and 1 ml fractions were collected. The fractions containing peptide were identified by a biuret assay and then amalgamated, and the solvent was removed by freeze drying.
The purified peptide (6 mg) and carrier protein (keyholelimpet haemocyanin or ovalbumin) (6 mg) were dissolved in 3 ml of0.1 M NaHCO3containing 6 patches on the back of a rabbit. Subsequent injections were with Freund's incomplete adjuvant and were perf6rmed on a 4-6-weekly cycle. Each rabbit was bled from the ear vein at least 1 week before the first injection (pre-immune serum) and 7-10 days after each injection (antiserum). Serum was prepared and stored at -80 C. E.l.i.s.a.
A 10 lg portion of peptide-ovalbumin conjugate in 50 1l of 0.05 M Na2C03, pH 9.6, was added to each well of a 96-well microtitre plate and incubated at 4 'C for 15 h. The wells were emptied and washed with 3 x 200 ,ul of 0.5 M NaCl/20 mM Tris, Western blotting analysis Membrane proteins (500 ,ug) from different tissues were separated by SDS/PAGE under reducing conditions as described in Leonard et al. (1988) . The proteins were transferred electrophoretically to nitrocellulose membranes by using an LKB 2117 Multiphor II Electrophoresis unit at a constant current (mA) of 1.2 x area (cm2), for 2 h.
The nitrocellulose was stained in 0.2 % (w/v) Ponceau S/5 % (v/v) acetic acid/20 % (v/v) propan-2-ol for 1.5 min to reveal the protein bands and molecular-mass markers. The nitrocellulose was cut into appropriate lanes and incubated in 30% (w/v) gelatin in TBS for 90 min at 37 'C to decrease non-specific binding of antisera. The lanes were then incubated with the antiserum (diluted 1/50-1/200) in 1 % (w/v) gelatin in TBS with gentle mixing for 15 h at 25 OC.
The antiserum solution was then decanted and stored at 4 'C in the presence of 0.05 % (w/v) thimerizole. This solution could be used for two additional incubations. The lanes were washed for 2 x 10 min in 0.05 % Tween 20 in TBS, and twice in TBS. The lanes were then incubated with horseradish-peroxidaseconjugated swine anti-rabbit immunoglobulin (diluted 1/1000 in 1 % gelatin in TBS) for 2 h at room temperature with gentle mixing. The second antibody solution was decanted and the lanes were washed as above. The proteins recognized by the primary antiserum were then detected by addition of colour reagent. The colour reagent was prepared by dropwise addition to 8 ml of TBS of a solution of 6 mg of 4-chloro-1-naphthol in will be designated IA and 1B, and the. antisera obtained with peptide-2 will be designated as 2A and 2B.
Western blot analysis
Western blot analysis was performed with the various antisera by using a D2-dopamine-receptor-rich brain region (caudate nucleus) and one with few or no D2 dopamine receptors (cerebellum) as a comparison. When antisera from some rabbits (IA, 2A) were used, multiple bands were labelled in analyses of both brain regions. Some bands were specific to the caudate nucleus, but overall the patterns were not informative. Other antisera (1B, 2B) provided much simpler patterns (Figure 1) . Antiserum lB labelled a major species of 95 kDa in caudate nucleus, but not in cerebellum. Antiserum 2B identified 95 kDa and 40 kDa bands as major species in caudate nucleus, and these bands were also seen when other D2-dopamine-receptor-rich brain regions were tested (olfactory tubercle, putamen). When the cerebellum was tested, the 40 kDa species was present, but less strongly, and for the 95 kDa species a very faint band was visible. Neither the 95 kDa nor the 40 kDa species was seen in the different brain regions when preimmune serum was used in place of antiserum.
When the experiments were repeated with antiserum 2B pretreated with the corresponding peptide-2 (250 ,ug/ml), the labelling of the 95 kDa species was decreased considerably in caudate nucleus. The above experiments with antiserum 2B were performed with bovine brain, but when membranes of whole rat brain (minus cerebellum) were analysed major labelled bands of 95 kDa and 38 kDa and a minor band of 65 kDa (results not shown) were detected.
Antiserum 2B was also tested against membranes from a recombinant CHO cell line expressing the long form of the D2 dopamine receptor (Castro and Strange, 1992 (Castro and Strange, 1992) (Figure 4 Chazot and Strange (1992a) , which yields a preparation in which agonist binding is sensitive to guanine nucleotides, i.e. receptor/G-protein coupling is present.
Receptor/G-protein coupling was assayed from the effect of GTP (100 ,tM) on dopamine/[3H]spiperone competition curves ( Figure 5 ).
None of the treatments (preimmune serum or antiserum) altered [3H]spiperone binding to the preparations. In the presence of preimmune serum, the dopamine/[3H]spiperone competition curve was characterized by a Hill coefficient less than 1, and a two-binding-site model was the best fit to the data. Addition of GTP shifted the competition curve to higher coLcentrations. In the presence of GTP, the dopamine competition curve was still best fitted by a two-binding-site model and there were changes in both the affinities and proportions of the two binding sites. The results obtained with antiserum IA (not shown) were essentially identical with those obtained with the preimmune serum. When antiserum 2B was tested, however, the effects of GTP on dopamine competition were largely eliminated. The antiserum induced a shift in the dopamine competition curve to higher concentrations. This effect can be seen as a change in the affinities of both the higher-and lower-affinity dopamine-binding sites. In the presence of antiserum 2B, dopamine competition curves (with or without GTP) fitted best to two-site models.
DISCUSSION
In this report we have described the production of antisera directed against two peptides derived from the sequence of D2 dopamine receptors and the characterization of their antireceptor activity. Others have reported the production of analogous antisera (David and Fuchs, 1991; McVittie et al., 1991; Plug et al., 1992) , but this is the first full structural and functional characterization.
Two peptides were chosen for evaluation, peptide-1, a 11 -mer from the putative second extracellular loop, and peptide-2, a 13-mer from the putative third intracellular loop. Both peptides are common to the short and long versions of the D2 dopamine receptor (Strange, 1990) and should not show cross-reactivity with other receptors. In each case, high-titre anti-peptide antisera were obtained in rabbits with titres comparable with those reported in other systems (e.g. Duggan and Stephenson, 1989) .
Western blot analysis was used to determine the reactivity of the anti-peptide antisera with denatured D2 dopamine receptor. Tissues rich in D2 dopamine receptors, e.g. caudate nucleus, and tissues with few or no D2 receptors, e.g. cerebellum, were compared to establish specificity. One antiserum against peptide-1 (lA) labelled a wide range of species in bovine caudate nucleus. Although these were mostly specific to the caudate nucleus and not seen in cerebellum, the multiplicity of the species rendered this antiserum less useful for use in Western blot analysis.
By contrast, a second antiserum against peptide-1 (1B) and an antiserum against peptide-2 (2B) showed strong labelling of a band of 95 kDa in caudate nucleus, which was either not seen in cerebellum (iB) or present at much decreased levels (2B). The size of this species corresponds to the principal species seen in photoaffinity labelling and in purification studies on D2 dopamine receptors from bovine caudate nucleus , so we presume this corresponds to the D2 dopamine receptor. A similar band was seen in Western blots of bovine olfactory tubercle and putamen, two other tissues rich in D2 dopamine receptors. Similarly, in rat brain the same species was observed. Labelling of the 95 kDa species by antiserum 2B in caudate nucleus could be blocked by the corresponding peptide, supporting the specificity of the interaction. The labelling of a faint band at 95 kDa in cerebellum by antiserum 2B was unexpected, as this tissue contains no D2-1ike receptors, as judged by ligandbinding experiments with 3H-labelled ligands (Chazot and Strange, 1992b) . Using '251-labelled ligands, however, Martres et al. (1985a,b) have shown that D2-like receptors are present in cerebellum, but at a level 1 % of that in caudate nucleus. Molecular-biology studies have suggested somewhat larger relative amounts of mRNA for D2-like receptors in cerebellum (O'Malley et al., 1990; Gandleman et al., 1991) .
In recombinant CHO cells expressing D2 dopamine receptors a band of 80 kDa was labelled by antiserum 2B, and this band was absent from untransfected CHO cells. The different size of the receptor expressed in CHO cells and in brain presumably reflects differences in glycosylation.
In immunoprecipitation studies, antisera against both peptides were found to be able to deplete soluble D2 dopamine receptors from a preparation of bovine caudate nucleus, showing that they react with the native receptor. The degree of immunoprecipitation compares favourably with that seen in other studies on related systems, e.g. for 5HTlA 5-hydroxytryptamine receptors (El Mestikawy et al., 1990) . The inability to precipitate more than 20 % of the soluble receptors may reflect constraints of the assay system, but could also (for peptide-2) reflect modification of the peptide sequence in the native state, e.g. by phosphorylation.
Antisera lB and 2B were used to localize D2 dopamine receptors on recombinant CHO cells bearing the gene for the long form of the D2 dopamine receptor and expressing the protein at high levels. The fluorescence was seen to be distributed uniformly over the cell, and there was little or no fluorescence seen with the parent untransfected CHO cell line. The antisera raised here may be of use in localizing receptors in tissues such as brain.
Peptide-2 used in this study is derived from the putative third intracellular loop of the D2 dopamine receptor (Bunzow et al., 1988) . For other G-protein-linked receptors, the putative third intracellular loop is thought to be a major site of receptor/ G-protein interaction (see, e.g., Liggett et al., 1991) . Therefore the antisera against peptide-2 might interfere with receptor/ G-protein coupling at the D2 dopamine receptor. Secondarystructure predictions on the putative third intracellular loop of the D2 dopamine receptor (results not shown) suggest that the only region of this loop likely to form a-helical structure corresponds to peptide-2. It is believed for the ,-adrenergic receptor that receptor/G-protein interaction depends in part on the contact between an a-helical region of the receptor in the third intracellular loop and a predicted a-helix in the C-terminal region of the G-protein (Strader et al., 1989) . Thus the region of the D2 dopamine receptor corresponding to peptide-2 may be of particular significance in receptor/G-protein coupling.
Receptor/G-protein interaction was assessed from the ability of GTP to decrease the affinity of dopamine for binding to the receptor. When introduced into this system, antisera against peptide-l (1A) behaved similarly to preimmune-serum controls, both having no effect on receptor/G-protein coupling. This is as expected, as peptide-1 is from the second extracellular loop of the receptor, a region thought not to be important for receptor/Gprotein interaction. In contrast, an antiserum against peptide-2 (2B) substantially affected agonist binding to the receptor. The affinity of the agonist dopamine was substantially decreased, and superficially at least the antiserum behaved like GTP itself. Given that it is thought that the effects of GTP are to dissociate receptor/G-protein interaction (Gilman, 1987) , then the antiserum can be seen to be achieving the same. This could then be via the binding of the antiserum to peptide-2 in the third intracellular loop of the receptor, which sterically prevents receptor/G-protein interaction. An antibody is a rather large molecule, so that its effects may be exerted over a long distance, but the' observation is at least consistent with the third intracellular loop of the D2 dopamine receptor being important for receptor/G-protein interaction. Analogous observations have been made for opiate receptors, but using anti-G-protein antibodies (McKenzie and Milligan, 1990 ). The present results suggest that antisera directed against the third intracellular loop of the receptor may be useful for identifying dopamine-induced responses linked to D2 receptors.
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